ADHD Assessment vs ADHD Screening: What's the Difference and Why It Matters

They sound similar but do very different things. Here's what each one actually tells you — and why the distinction matters for getting the right diagnosis and the right care.

If you've taken an online ADHD quiz, filled out a questionnaire at your GP's office, or scored high on a self-report scale, you might be wondering: does this mean I have ADHD?

The short answer is no — not yet. What you've done is a screening, and screening is not the same thing as a diagnostic assessment. They're different tools designed to answer different questions, and confusing the two can lead to real problems in either direction: thinking you have a diagnosis when you don't, or thinking you've been cleared when you haven't actually been properly assessed.

This matters more than it might seem, because the gap between a screening result and a diagnosis is where both underdiagnosis and misdiagnosis happen. Understanding what each step does — and what it can't do — puts you in a much stronger position to navigate the system and get the right care.

Screening asks "should we look further?" Assessment asks "what's actually going on?"

This is the core distinction, and everything else follows from it.

ADHD screening is a first-pass filter. It's quick, usually self-administered, and designed to flag whether ADHD is plausible enough to warrant a fuller evaluation. It might happen in a GP's office, through a mental health intake form, or via an online tool. A positive screening result means "this is worth investigating." It does not mean "you have ADHD."

ADHD assessment is the diagnostic process. It's slower, more thorough, and conducted by a clinician with expertise in ADHD and related conditions. It involves a detailed clinical interview, developmental history, collateral information, functional impairment review, differential diagnosis, and a medical screen. It ends with a clinical judgement about whether you meet diagnostic criteria — and if so, what your care plan should look like.

The Australian ADHD guideline and international guidelines like NICE are explicit on this point: ADHD should not be diagnosed on the basis of rating scales or screening tools alone. A positive screen should always be followed by a comprehensive assessment.

What ADHD screening tools actually do

Screening tools are designed to be quick, accessible, and sensitive enough to catch most people who might have ADHD. The trade-off is that they also catch some people who don't — because the symptoms they measure (difficulty concentrating, restlessness, forgetfulness, impulsivity) overlap with a lot of other conditions.

The most commonly used validated screening tools for adults include:

ASRS (Adult ADHD Self-Report Scale) — developed by the WHO, this is the most widely used adult ADHD screener. The six-item version takes a few minutes and is designed for quick case-finding in primary care, community settings, and triage. The newer ASRS-5, updated for DSM-5, has the strongest current evidence for brief screening across general and primary care settings.

WURS-25 (Wender Utah Rating Scale) — this screens for childhood ADHD symptoms retrospectively, which is useful because the diagnostic criteria require evidence that symptoms were present before age 12. It's often used alongside a current-symptom screener to help build the developmental picture.

These tools can be genuinely useful. They open the door to conversations that might not otherwise happen, particularly for adults who've spent years assuming their difficulties were personality flaws rather than something with a name and a treatment pathway.

But they have real limits. Screening accuracy drops in people with co-occurring conditions — depression, anxiety, bipolar disorder, personality disorders, trauma, sleep problems, and substance use can all produce scores that look like ADHD on a short questionnaire. A 2024 systematic review of adult ADHD screeners in primary care found that while several tools performed well in general populations, study quality varied and accuracy was affected by the clinical complexity of the sample.

A screening tool can't tell you why you're struggling to concentrate. It can only tell you that you are.

What a full assessment adds — and why it matters

If screening asks "is ADHD plausible?", assessment asks "is this actually ADHD, what else might be going on, and what should we do about it?"

A proper adult ADHD assessment in Australia is structured around the DSM-5 diagnostic criteria. It should cover:

Current symptoms mapped to DSM-5 criteria. Not just "do you have trouble focusing?" but a systematic review of the specific inattentive and hyperactive-impulsive symptoms, whether enough criteria are met, and how those symptoms show up across your work, relationships, home life, and daily functioning.

Developmental history and childhood onset. The DSM-5 requires evidence that symptoms were present before age 12. Your clinician should explore your childhood in detail — school experience, behavioural patterns, family observations — because many adults with ADHD were never identified as children, especially women and those who developed compensatory strategies early.

Collateral information. Input from someone who knows you well — a partner, parent, sibling, or friend — or historical documents like school reports. This strengthens the evidence base for the diagnosis and reduces reliance on self-report alone.

Functional impairment. ADHD diagnosis requires that symptoms cause clinically significant impairment, not just inconvenience. A good assessment looks at how deeply your difficulties affect your work, finances, relationships, self-care, and quality of life — and whether the effort it takes you to function is disproportionate to what others experience.

Differential diagnosis and co-occurring conditions. This is where depth really counts. Depression, anxiety, trauma, bipolar disorder, sleep disorders, substance use, autism, and learning difficulties can all look like ADHD, co-exist with it, or develop as a consequence of it. A proper assessment actively explores these possibilities rather than assuming ADHD is the only explanation.

Medical review and substance use screening. Some medical conditions can mimic ADHD symptoms, and substance use both complicates diagnosis and affects prescribing safety. These need to be addressed before a treatment plan is built.

The depth of assessment is what protects you. It's the difference between a diagnosis you can trust and a label that might be wrong.

Why getting this distinction right matters

This isn't just an academic point. The gap between screening and assessment is where real harm can happen — in both directions.

The risk of underdiagnosis

If someone screens negative — or if screening never happens at all — they might never get referred for a proper assessment. This is particularly common for adults who don't fit the stereotypical picture of ADHD: women, people with primarily inattentive presentations, and those whose compensatory strategies have masked the extent of their difficulties. The Australian guideline notes that failure to diagnose means failure to offer effective treatment. For adults who've spent decades wondering why things feel so much harder for them than for everyone else, a missed diagnosis has real consequences for work, relationships, mental health, and self-understanding.

The risk of misdiagnosis

If someone screens positive and that result is treated as a diagnosis — without a proper assessment to explore what else might be going on — the consequences can be just as serious. Depression, anxiety, bipolar disorder, trauma, sleep disorders, and substance use can all produce ADHD-like symptoms on a screener. If the real cause is something else, ADHD treatment is unlikely to help and may delay the treatment that would.

This isn't hypothetical. Guidelines repeatedly warn against diagnosing ADHD from rating scales alone, and Australian commentary has raised concerns that some commercial models may encourage overly brief diagnostic pathways. The right conclusion isn't that rising demand proves overdiagnosis — it's that high demand makes assessment quality more important, not less.

What this means for you

If you've scored high on a screening tool, that's a meaningful data point — take it seriously, and use it to start a conversation with your GP or a clinician with ADHD expertise. But don't treat it as a finished answer. The screening did its job by flagging something worth investigating. The assessment is where the answers actually live.

What to look for when choosing a provider

Now that you understand the difference, you're in a better position to evaluate what a service is actually offering when they say "ADHD screening" or "ADHD assessment." A few things to look for:

Is the service offering screening, assessment, or both? Some services offer a screening step as part of a broader assessment pathway — that's fine. But if a service is offering a diagnosis based primarily on a questionnaire and a brief consultation, that doesn't meet the standard set by the Australian guideline.

Will the clinician assess against DSM-5 criteria? A proper assessment maps your symptoms to a formal diagnostic framework, explores childhood onset, and evaluates cross-setting impairment. If none of this is mentioned, ask.

Will co-occurring conditions be explored? An assessment that only looks for ADHD and nothing else risks missing the full picture. Good practice means actively screening for mood disorders, anxiety, trauma, sleep problems, substance use, and other neurodevelopmental conditions.

Will collateral be sought? Input from someone who knows you, or review of historical records, strengthens the diagnosis. If a service doesn't mention collateral, it's worth asking why.

What happens after diagnosis? A diagnosis without a care plan isn't finished care. Look for a service that connects assessment to ongoing treatment and support, rather than handing you a report and sending you on your way.

This is how Kantoko does it

At Kantoko, we don't offer standalone assessment without a pathway to act on it. Our model is built around a structured, DSM-5-aligned assessment conducted by ADHD Doctors — with the depth that guidelines say a proper diagnosis requires.

We front-load the clinical work. Before your appointment, we collect detailed clinical information and require collateral upfront. Your ADHD Doctor reviews all of it before they see you — so your appointment time is focused on the clinical interview, not filling in background.

We assess the full picture. Co-occurring conditions, developmental history, functional impairment, medical review — these aren't optional extras in our process. They're built in, because a diagnosis you can trust needs to be built on a thorough foundation.

Assessment connects to ongoing care. At Kantoko, your assessment isn't the end of the process — it's the beginning of a care relationship. Your treatment plan lives on our platform and is communicated directly with your regular GP. You're supported by a care team — ADHD Doctors, registered nurses, and our customer care team — with follow-ups based on clinical need.

We're built for continuity. If your needs change, if you move states, or if you need a different kind of support down the line, your care adapts with you rather than starting from scratch.

The difference between screening and assessment matters — and so does what comes after. We take both seriously.

If you're ready for an ADHD assessment that's thorough, structured, and connected to real ongoing care, Get started with Kantoko today.

This article is for informational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare provider for diagnosis and treatment options.